Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Supportive Care in Cancer
Erschienen in: Supportive Care in Cancer 12/2023

01.12.2023 | Research

Psychological distress as a risk factor for the efficacy of chemotherapy in advanced gastric cancer patients

verfasst von: Yongkang Zhang, Chen Gan, Jian Xu, Lulian Pang, Wen Li, Huaidong Cheng

Erschienen in: Supportive Care in Cancer | Ausgabe 12/2023

Einloggen, um Zugang zu erhalten

Abstract

Aim

To assess the relationship between psychological distress and quality of life (QoL), cancer-related fatigue (CRF), and chemotherapy efficacy in advanced gastric cancer patients.

Methods

Advanced gastric cancer patients (39 with psychological distress and 35 without psychological distress) completed the Distress Thermometer (DT), QoL, and CRF test before receiving chemotherapy and assessed the efficacy after completing 2 courses of chemotherapy.

Results

Psychological distress was a significant factor in the efficacy of chemotherapy in advanced gastric cancer patients (χ2 = 6.324; p = 0.042). Compared to advanced gastric cancer patients with no psychological distress, advanced gastric cancer patients with psychological distress had a poorer QoL (50.41 ± 6.17 vs. 60.01 ± 7.94, t =  − 5.882, p < 0.01) and more pronounced CRF (5.75 ± 1.16 vs. 3.22 ± 0.75, t = 11.231, p < 0.01) while receiving chemotherapy. FACT-G (p = 0.0035, r =  − 0.4568), as well as PFS (p < 0.0001, r = 0.6599), correlated significantly with efficacy for patients in the psychological distress group. The FACT-G (p = 0.0134, r =  − 0.4139) of patients in the no psychological distress group correlated significantly with efficacy.

Conclusion

Psychological distress has a negative impact on QoL, CRF, and efficacy and may be a potential risk for the efficacy of palliative chemotherapy in advanced gastric cancer patients.
Literatur
1.
Ajani JA, Lee J, Sano T, Janjigian YY, Fan D, Song S (2017) Gastric adenocarcinoma Nat Rev Dis Primers 3:17036PubMed
2.
Holland JC, Alici Y (2010) Management of distress in cancer patients. J Support Oncol 8(1):4–12PubMed
3.
Chung J, Ju G, Yang J, Jeong J, Jeong Y, Choi MK, Kwon J, Lee KH, Kim ST, Han HS (2018) Prevalence of and factors associated with anxiety and depression in Korean patients with newly diagnosed advanced gastrointestinal cancer. Korean J Intern Med 33(3):585–594PubMed
4.
Kim GM, Kim SJ, Song SK, Kim HR, Kang BD, Noh SH, Chung HC, Kim KR, Rha SY (2017) Prevalence and prognostic implications of psychological distress in patients with gastric cancer. BMC Cancer 17(1):283PubMedPubMedCentral
5.
Abu-Odah H, Molassiotis A, Zhao IY, Su JJ, Allsop MJ (2022) Psychological distress and associated factors among Palestinian advanced cancer patients: a cross-sectional study. Front Psychol 13:1061327PubMedPubMedCentral
6.
Fallowfield L (2002) Quality of life: a new perspective for cancer patients. Nat Rev Cancer 2(11):873–879PubMed
7.
Blazeby JM, Vickery CW (2001) Quality of life in patients with cancers of the upper gastrointestinal tract. Expert Rev Anticancer Ther 1(2):269–276PubMed
8.
Post MW (2014) Definitions of quality of life: what has happened and how to move on. Top Spinal Cord Inj Rehabil 20(3):167–180PubMedPubMedCentral
9.
Schütte K, Schulz C, Middelberg-Bisping K (2021) Impact of gastric cancer treatment on quality of life of patients. Best Pract Res Clin Gastroenterol 50–51:101727PubMed
10.
Deshields TL, Potter P, Olsen S, Liu J (2014) The persistence of symptom burden: symptom experience and quality of life of cancer patients across one year. Support Care Cancer 22(4):1089–1096PubMed
11.
Phoosuwan N, Lundberg PC (2022) Psychological distress and health-related quality of life among women with breast cancer: a descriptive cross-sectional study. Support Care Cancer 30(4):3177–3186PubMed
12.
Bergerot CD, Philip EJ, Bergerot PG, Pal SK (2020) Distress and quality of life among patients with advanced genitourinary cancers. Eur Urol Focus 6(6):1150–1154PubMed
13.
Brown LF, Kroenke K, Theobald DE, Wu J, Tu W (2010) The association of depression and anxiety with health-related quality of life in cancer patients with depression and/or pain. Psychooncology 19(7):734–741PubMedPubMedCentral
14.
Fabi A, Bhargava R, Fatigoni S, Guglielmo M, Horneber M, Roila F, Weis J, Jordan K, Ripamonti CI (2020) Cancer-related fatigue: ESMO Clinical Practice Guidelines for diagnosis and treatment. Ann Oncol 31(6):713–723PubMed
15.
Bower JE (2014) Cancer-related fatigue–mechanisms, risk factors, and treatments. Nat Rev Clin Oncol 11(10):597–609PubMedPubMedCentral
16.
Shitara K, Van Cutsem E, Bang YJ, Fuchs C, Wyrwicz L, Lee KW, Kudaba I, Garrido M, Chung HC, Lee J, Castro HR, Mansoor W, Braghiroli MI, Karaseva N, Caglevic C, Villanueva L, Goekkurt E, Satake H, Enzinger P, Alsina M, Benson A, Chao J, Ko AH, Wainberg ZA, Kher U, Shah S, Kang SP, Tabernero J (2020) Efficacy and safety of pembrolizumab or pembrolizumab plus chemotherapy vs chemotherapy alone for patients with first-line, advanced gastric cancer: the KEYNOTE-062 phase 3 randomized clinical trial. JAMA Oncol 6(10):1571–1580PubMed
17.
Park S, Nam CM, Kim SG, Mun JE, Rha SY, Chung HC (2021) Comparative efficacy and tolerability of third-line treatments for advanced gastric cancer: a systematic review with Bayesian network meta-analysis. Eur J Cancer 144:49–60PubMed
18.
19.
Yost KJ, Thompson CA, Eton DT, Allmer C, Ehlers SL, Habermann TM, Shanafelt TD, Maurer MJ, Slager SL, Link BK, Cerhan JR (2013) The Functional Assessment of Cancer Therapy - General (FACT-G) is valid for monitoring quality of life in patients with non-Hodgkin lymphoma. Leuk Lymphoma 54(2):290–297PubMed
20.
Zhang Q, Li F, Zhang H, Yu X, Cong Y (2018) Effects of nurse-led home-based exercise & cognitive behavioral therapy on reducing cancer-related fatigue in patients with ovarian cancer during and after chemotherapy: a randomized controlled trial. Int J Nurs Stud 78:52–60PubMed
21.
Dalhammar K, Malmström M, Schelin M, Falkenback D, Kristensson J (2020) The impact of initial treatment strategy and survival time on quality of end-of-life care among patients with oesophageal and gastric cancer: a population-based cohort study. PLoS ONE 15(6):e0235045PubMedPubMedCentral
22.
Wagner AD, Syn NL, Moehler M, Grothe W, Yong WP, Tai BC, Ho J, Unverzagt S (2017) Chemotherapy for advanced gastric cancer. Cochrane Database Syst Rev 8(8):CD004064
23.
Han L (2020) Prevalence, risk factors and prognostic role of anxiety and depression in surgical gastric cancer patients. Transl Cancer Res 9(3):1371–1383PubMedPubMedCentral
24.
Li W, Gan C, Zuo H, Yin X, Jing Y, Pang L, Yu S, Tang L, Yao S, Cheng H (2023) Psychological distress as risk factor for the efficacy of whole-brain radiotherapy in brain metastasis patients. Future Oncol 19(1):49–60PubMed
25.
Ettlin DA, Napimoga MH, Meira ECM, Clemente-Napimoga JT (2021) Orofacial musculoskeletal pain: an evidence-based bio-psycho-social matrix model. Neurosci Biobehav Rev 128:12–20PubMed
26.
Miles A, McClements PL, Steele RJ, Redeker C, Sevdalis N, Wardle J (2017) Perceived diagnostic delay and cancer-related distress: a cross-sectional study of patients with colorectal cancer. Psychooncology 26(1):29–36PubMed
27.
Lesage P, Portenoy RK (2002) Management of fatigue in the cancer patient. Oncology (Williston Park) 16(3):373–8, 381 (discussion 381-2, 385-6, 388-9)PubMed
28.
Stone P, Richards M, A’Hern R, Hardy J (2000) A study to investigate the prevalence, severity and correlates of fatigue among patients with cancer in comparison with a control group of volunteers without cancer. Ann Oncol 11(5):561–567PubMed
29.
Ahlberg K, Ekman T, Wallgren A, Gaston-Johansson F (2004) Fatigue, psychological distress, coping and quality of life in patients with uterine cancer. J Adv Nurs 45(2):205–213PubMed
30.
Syrowatka A, Motulsky A, Kurteva S, Hanley JA, Dixon WG, Meguerditchian AN, Tamblyn R (2017) Predictors of distress in female breast cancer survivors: a systematic review. Breast Cancer Res Treat 165(2):229–245PubMedPubMedCentral
31.
Chad-Friedman E, Coleman S, Traeger LN, Pirl WF, Goldman R, Atlas SJ, Park ER (2017) Psychological distress associated with cancer screening: a systematic review. Cancer 123(20):3882–3894PubMed
32.
DiMatteo MR, Lepper HS, Croghan TW (2000) Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 160(14):2101–2107PubMed
33.
Moreno-Smith M, Lutgendorf SK, Sood AK (2010) Impact of stress on cancer metastasis. Future Oncol 6(12):1863–1881PubMed
34.
Dai S, Mo Y, Wang Y, Xiang B, Liao Q, Zhou M, Li X, Li Y, Xiong W, Li G, Guo C, Zeng Z (2020) Chronic stress promotes cancer development. Front Oncol 10:1492PubMedPubMedCentral
35.
Nissen MD, Sloan EK, Mattarollo SR (2018) β-Adrenergic signaling impairs antitumor CD8(+) T-cell responses to B-cell lymphoma immunotherapy. Cancer Immunol Res 6(1):98–109PubMed
36.
Baek JH, Lee H, Myung W, Kim H, Choi YH, Kim DK, Hong KS, Choi H (2019) The association between inflammatory markers and general psychological distress symptoms. Gen Hosp Psychiatry 56:9–12PubMed
37.
Baritaki S, de Bree E, Chatzaki E, Pothoulakis C (2019) Chronic stress, inflammation, and colon cancer: a crh system-driven molecular crosstalk. J Clin Med 8(10):1669PubMedPubMedCentral
38.
Molfino A, Formiconi A, Rossi Fanelli F, Muscaritoli M (2014) Ghrelin: from discovery to cancer cachexia therapy. Curr Opin Clin Nutr Metab Care 17(5):471–6PubMed
39.
Fu L, Feng X, Jin Y, Lu Z, Li R, Xu W, Chang VT, Hu Y, Ye X (2022) Symptom clusters and quality of life in gastric cancer patients receiving chemotherapy. J Pain Symptom Manage 63(2):230–243PubMed
40.
Compen F, Bisseling E, Schellekens M, Donders R, Carlson L, van der Lee M, Speckens A (2018) Face-to-face and internet-based mindfulness-based cognitive therapy compared with treatment as usual in reducing psychological distress in patients with cancer: a multicenter randomized controlled trial. J Clin Oncol 36(23):2413–2421PubMed
41.
Lei Chui P, Wai S, Lai LL, See MH, Tan SB (2021) Mindful breathing: effects of a five-minute practice on perceived stress and mindfulness among patients with cancer. Clin J Oncol Nurs 25(2):174–180PubMed
42.
Hejazi F, Bahrami M, Keshvari M, Alavi M (2017) The effect of a communicational program on psychological distress in the elderly suffering from cancer. Iran J Nurs Midwifery Res 22(3):201–207PubMedPubMedCentral
43.
Clark PG (2010) Decreasing psychological distress in cancer inpatients using FLEX Care®: a pilot study. Soc Work Health Care 49(9):872–890PubMed
44.
Rossetti A, Chadha M, Torres BN, Lee JK, Hylton D, Loewy JV, Harrison LB (2017) The impact of music therapy on anxiety in cancer patients undergoing simulation for radiation therapy. Int J Radiat Oncol Biol Phys 99(1):103–110PubMedPubMedCentral
45.
Lundt A, Jentschke E (2019) Long-term changes of symptoms of anxiety, depression, and fatigue in cancer patients 6 months after the end of yoga therapy. Integr Cancer Ther 18:1534735418822096PubMedPubMedCentral
46.
Zhang X, Zhang Y, He Z, Yin K, Li B, Zhang L, Xu Z (2019) Chronic stress promotes gastric cancer progression and metastasis: an essential role for ADRB2. Cell Death Dis 10(11):788PubMedPubMedCentral
Metadaten
Titel
Psychological distress as a risk factor for the efficacy of chemotherapy in advanced gastric cancer patients
verfasst von
Yongkang Zhang
Chen Gan
Jian Xu
Lulian Pang
Wen Li
Huaidong Cheng
Publikationsdatum
01.12.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 12/2023
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-023-08143-1

Weitere Artikel der Ausgabe 12/2023

Supportive Care in Cancer 12/2023 Zur Ausgabe

Research

A pilot randomized, placebo-controlled, double-blind study of omega-3 fatty acids to prevent paclitaxel-associated acute pain syndrome in breast cancer patients: Alliance A22_Pilot2

Research

Hangeshashinto for prevention of oral mucositis in patients undergoing hematopoietic stem cell transplantation: a randomized phase II study

Correspondence

Letter to the editor: trismus, health‐related quality of life, and trismus‐related symptoms up to 5 years post‐radiotherapy for head and neck cancer treated between 2007 and 2012

Research

“Take the tablet or don’t take the tablet?”—A qualitative study of patients’ experiences of self-administering anti-cancer medications related to adherence and managing side effects

Research

A qualitative study on the healthcare experiences of adolescents and young adults (AYA) with an uncertain or poor cancer prognosis

Research

Patients’ views and experiences on the supported self-management/patient-initiated follow up pathway for breast cancer

Neu im Fachgebiet Onkologie

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Alter verschlechtert Prognose bei Endometriumkarzinom

11.05.2024 Endometriumkarzinom Nachrichten

Ein höheres Alter bei der Diagnose eines Endometriumkarzinoms ist mit aggressiveren Tumorcharakteristika assoziiert, scheint aber auch unabhängig von bekannten Risikofaktoren die Prognose der Erkrankung zu verschlimmern.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise